ロード中...
PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS IN THE 21st CENTURY: FOCUS ON RITUXIMAB
Rheumatoid arthritis (RA) is one of the most common and severe chronic inflammatory diseases. The paper reviews the recent studies evaluating the efficacy of rituximab (MabThera®), chimeric anti-CD20 monoclonal antibodies in B cells, in patients with RA. It has been shown that Rituximab is an extrem...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Russo |
| 出版事項: |
IMA-PRESS LLC
2009-12-01
|
| シリーズ: | Современная ревматология |
| 主題: | |
| オンライン･アクセス: | https://mrj.ima-press.net/mrj/article/view/261 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|